SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form F-3 - Registration statement by foreign private issuers:
SEC Accession No. 0001104659-24-045306
Filing Date
2024-04-10
Accepted
2024-04-09 18:12:11
Documents
12

Document Format Files

Seq Description Document Type Size
1 FORM F-3 tm249599d1_f3.htm F-3 281565
2 EXHIBIT 4.5 tm249599d1_ex4-5.htm EX-4.5 296065
3 EXHIBIT 4.6 tm249599d1_ex4-6.htm EX-4.6 300169
4 EXHIBIT 5.1 tm249599d1_ex5-1.htm EX-5.1 75180
5 EXHIBIT 23.1 tm249599d1_ex23-1.htm EX-23.1 3937
6 EXHIBIT 23.2 tm249599d1_ex23-2.htm EX-23.2 3052
7 EXHIBIT 23.3 tm249599d1_ex23-3.htm EX-23.3 3809
8 EX-FILING FEES tm249599d1_ex-filingfees.htm EX-FILING FEES 26191
9 GRAPHIC tm249599-1_f3img001.jpg GRAPHIC 30301
10 GRAPHIC tm249599d1_ex23-1img001.jpg GRAPHIC 7665
11 GRAPHIC image_002.jpg GRAPHIC 14360
12 GRAPHIC image_001.gif GRAPHIC 510
  Complete submission text file 0001104659-24-045306.txt   1064442
Mailing Address NO. 152 HONGLIANG EAST 1ST STREET NO. 1703, TIANFU NEW DISTRICT CHENGDU F4 610200
Business Address NO. 152 HONGLIANG EAST 1ST STREET NO. 1703, TIANFU NEW DISTRICT CHENGDU F4 610200 86-0937-2689523
Qilian International Holding Group Ltd (Filer) CIK: 0001779578 (see all company filings)

IRS No.: 000000000 | State of Incorp.: E9 | Fiscal Year End: 0930
Type: F-3 | Act: 33 | File No.: 333-278591 | Film No.: 24833766
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)